A critical conversation with Planet Hope
Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.
Clinical trials get the green light
Human trials of a microwearable sensor for the detection of dangerous dehydration levels are set to begin after the latest successful fundraising round for HealthTech firm WearOptimo. The $5 million boost will enable the company to progress its game-changing hydration monitor, through clinical trials at QUT.
WearOptimo backed by Aspen Medical in multi-million-dollar strategic deal
A multi-million-dollar investment agreement by Aspen Medical in Queensland-based health-tech company WearOptimo, has cemented a strategic partnership between the two companies to revolutionise precision medicine globally.
Major global honour for master of Microwearables
An Aussie inventor and entrepreneur reshaping the future of global healthcare with Microwearable technology has been recognised for the incredible impact of his work.
WearOptimo’s strategic partnership agreement with Aspen Medical
A key milestone on our commercial journey was reached today with the announcement of a partnership between WearOptimo and Aspen Medical.
Professor Mark Kendall with Harvard Club of Australia
Can Australia become a world leader in personalised medicine? Professor Mark Kendall discusses with Harvard Club of Australia.
New stick-on coronavirus warning device: Nine News Queensland
A team of Queensland scientists is tonight developing a stick-on coronavirus warning device allowing doctors to predict which patients will need intensive care. @9NewsQueensland
WearOptimo drives forward Microwearables with $2.5 million in funding
In a recent announcement from Acting Health Minister Hon. Alan Tudge MP, WearOptimo received the news that it is to receive $980,000 from the Australian Federal Government as part of the BioMedTech Horizons (BMTH) program.
Prof Mark Kendall invited to act as co-chair of government initiative supporting stem cell therapies
Professor Mark Kendall has been invited to act as co-chair of the Expert Advisory Panel of the Stem Cell Therapies Mission, helping world-class Australian researchers further investigate game-changing medical treatments for many chronic and inherited diseases.
WearOptimo hosts event celebrating the ‘Best of Brisbane’ in biomedical engineering
With a growing number of MedTech companies being established in the field of innovative and revolutionary medical devices, Brisbane is quickly becoming a hub for medical engineers.